Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Surgery Partners, Inc. Director's Dealing 2022

Mar 17, 2022

31430_dirs_2022-03-17_cacf5baa-de55-4007-8049-94f96bf982ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2022-03-15

Reporting Person: Goodwin George (President, ASC Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-15 Common Stock S 7761 $49.32 Disposed 94429 Direct
2022-03-15 Common Stock M 33000 $13.42 Acquired 127429 Direct
2022-03-15 Common Stock S 18786 $50.01 Disposed 108643 Direct
2022-03-16 Common Stock S 1697 $50.88 Disposed 106946 Direct
2022-03-16 Common Stock S 12500 $52.07 Disposed 94446 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-15 Stock Option (Right to Buy) $13.42 M 33000 Disposed 2029-03-15 Common Stock (33000.0) Direct

Footnotes

F1: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.

F2: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.